{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T06:36:18Z","timestamp":1794724578589,"version":"4.9.1"},"reference-count":47,"publisher":"American Society of Hematology","issue":"13","license":[{"start":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T00:00:00Z","timestamp":1712188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7,9]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>Multiple myeloma is characterized by frequent clinical relapses after conventional therapy. Recently, chimeric antigen receptor (CAR) T cells targeting B-cell maturation antigen (BCMA) has been established as a treatment option for patients with relapsed or refractory disease. However, although &amp;gt;70% of patients initially respond to this treatment, clinical relapse and disease progression occur in most cases. Recent studies showed persistent expression of BCMA at the time of relapse, indicating that immune-intrinsic mechanisms may contribute to this resistance. Although there were no preexisting T-cell features associated with clinical outcomes, we found that patients with a durable response to CAR T-cell treatment had greater persistence of their CAR T cells than patients with transient clinical responses. They also possessed a significantly higher proportion of CD8+ T-effector memory cells. In contrast, patients with short-lived responses to treatment have increased frequencies of cytotoxic CD4+ CAR T cells. These cells expand in\u00a0vivo early after infusion but express exhaustion markers (hepatitis A virus cellular receptor 2 [HAVCR2] and T-cell immunoglobulin and mucin domain-containing-3 [TIGIT]) and remain polyclonal. Finally, we demonstrate that nonclassical monocytes are enriched in the myeloma niche and may induce CAR T-cell dysfunction through mechanisms that include transforming growth factor \u03b2. These findings shed new light on the role of cytotoxic CD4+ T cells in disease progression after CAR T-cell therapy.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2023012416","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T20:01:52Z","timestamp":1712260912000},"page":"3562-3575","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":59,"title":["CD4+ CAR T-cell exhaustion associated with early relapse of multiple myeloma after BCMA CAR T-cell therapy"],"prefix":"10.1182","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0443-6066","authenticated-orcid":false,"given":"Guy","family":"Ledergor","sequence":"first","affiliation":[{"name":"1Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7309-8331","authenticated-orcid":false,"given":"Zenghua","family":"Fan","sequence":"additional","affiliation":[{"name":"1Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wu","sequence":"additional","affiliation":[{"name":"1Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA"},{"name":"2Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0073-4069","authenticated-orcid":false,"given":"Elizabeth","family":"McCarthy","sequence":"additional","affiliation":[{"name":"3Institute for Human Genetics, University of California, San Francisco, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1239-4954","authenticated-orcid":false,"given":"Axel","family":"Hyrenius-Wittsten","sequence":"additional","affiliation":[{"name":"4Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA"},{"name":"5Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5266-9660","authenticated-orcid":false,"given":"Alec","family":"Starzinski","sequence":"additional","affiliation":[{"name":"1Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9760-2304","authenticated-orcid":false,"given":"Hewitt","family":"Chang","sequence":"additional","affiliation":[{"name":"1Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2997-981X","authenticated-orcid":false,"given":"Mark","family":"Bridge","sequence":"additional","affiliation":[{"name":"1Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5097-2711","authenticated-orcid":false,"given":"Serena","family":"Kwek","sequence":"additional","affiliation":[{"name":"1Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Cheung","sequence":"additional","affiliation":[{"name":"1Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Bylsma","sequence":"additional","affiliation":[{"name":"1Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Hansen","sequence":"additional","affiliation":[{"name":"6Department of Orthopedic Surgery, University of California, San Francisco, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Wolf","sequence":"additional","affiliation":[{"name":"1Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandy","family":"Wong","sequence":"additional","affiliation":[{"name":"1Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Shah","sequence":"additional","affiliation":[{"name":"1Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kole T.","family":"Roybal","sequence":"additional","affiliation":[{"name":"4Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA"},{"name":"7Parker Institute for Cancer Immunotherapy, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Martin","sequence":"additional","affiliation":[{"name":"1Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun J.","family":"Ye","sequence":"additional","affiliation":[{"name":"3Institute for Human Genetics, University of California, San Francisco, San Francisco, CA"},{"name":"7Parker Institute for Cancer Immunotherapy, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6428-428X","authenticated-orcid":false,"given":"Lawrence","family":"Fong","sequence":"additional","affiliation":[{"name":"1Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA"},{"name":"2Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA"},{"name":"7Parker Institute for Cancer Immunotherapy, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2024,7,9]]},"reference":[{"issue":"18","key":"2024071516104547500_bib1","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJMra041875","article-title":"Multiple myeloma","volume":"351","author":"Kyle","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"2024071516104547500_bib2","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple myeloma","volume":"364","author":"Palumbo","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"2024071516104547500_bib3","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1182\/blood-2012-01-405977","article-title":"Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides","volume":"120","author":"Egan","year":"2012","journal-title":"Blood"},{"issue":"4","key":"2024071516104547500_bib4","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/s41375-020-0734-z","article-title":"B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches","volume":"34","author":"Shah","year":"2020","journal-title":"Leukemia"},{"issue":"8","key":"2024071516104547500_bib5","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1158\/1078-0432.CCR-12-2422","article-title":"B-cell maturation antigen is a promising target for adoptive T-cell therapy of multiple myeloma","volume":"19","author":"Carpenter","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"22","key":"2024071516104547500_bib6","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1200\/JCO.2018.77.8084","article-title":"T\u00a0cells genetically modified to express an anti\u2013B-cell maturation antigen chimeric antigen receptor cause remissions of poor-prognosis relapsed multiple myeloma","volume":"36","author":"Brudno","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"2024071516104547500_bib7","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1172\/JCI126397","article-title":"B cell maturation antigen-specific CAR T cells are clinically active in multiple myeloma","volume":"129","author":"Cohen","year":"2019","journal-title":"J Clin Invest"},{"issue":"18","key":"2024071516104547500_bib8","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1056\/NEJMoa1817226","article-title":"Anti-BCMA CAR T-cell therapy bb2121 in relapsed or refractory multiple myeloma","volume":"380","author":"Raje","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"10297","key":"2024071516104547500_bib9","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0140-6736(21)00933-8","article-title":"Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b\/2 open-label study","volume":"398","author":"Berdeja","year":"2021","journal-title":"Lancet"},{"issue":"4","key":"2024071516104547500_bib10","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1158\/2159-8290.CD-12-0548","article-title":"The basic principles of chimeric antigen receptor design","volume":"3","author":"Sadelain","year":"2013","journal-title":"Cancer Discov"},{"issue":"1","key":"2024071516104547500_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41409-020-01023-w","article-title":"Chimeric antigen receptor T cell therapy in multiple myeloma: promise and challenges","volume":"56","author":"Dhakal","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"2024071516104547500_bib12","first-page":"372","article-title":"Mechanisms of resistance to CAR T cell therapy","volume":"16","author":"Shah","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"2024071516104547500_bib13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41577-018-0119-y","article-title":"CAR T cell therapy: inroads to response and resistance","volume":"19","author":"Brown","year":"2019","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"2024071516104547500_bib14","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ccell.2023.02.008","article-title":"The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients","volume":"41","author":"Friedrich","year":"2023","journal-title":"Cancer Cell"},{"key":"2024071516104547500_bib15","article-title":"DoubletDetection","author":"Gayoso","year":"2020","journal-title":"Zenodo"},{"issue":"1","key":"2024071516104547500_bib16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13059-017-1382-0","article-title":"SCANPY: large-scale single-cell gene expression data analysis","volume":"19","author":"Wolf","year":"2018","journal-title":"Genome Biol"},{"issue":"12","key":"2024071516104547500_bib17","doi-asserted-by":"crossref","first-page":"111384","DOI":"10.1016\/j.celrep.2022.111384","article-title":"Circulating monocytes associated with anti-PD-1 resistance in human biliary cancer induce T cell paralysis","volume":"40","author":"Keenan","year":"2022","journal-title":"Cell Rep"},{"issue":"1","key":"2024071516104547500_bib18","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","article-title":"Adjusting batch effects in microarray expression data using empirical Bayes methods","volume":"8","author":"Johnson","year":"2007","journal-title":"Biostatistics"},{"issue":"12","key":"2024071516104547500_bib19","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat Methods"},{"issue":"1","key":"2024071516104547500_bib20","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.1038\/s41598-019-41695-z","article-title":"From Louvain to Leiden: guaranteeing well-connected communities","volume":"9","author":"Traag","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"2024071516104547500_bib21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nbt.4314","article-title":"Dimensionality reduction for visualizing single-cell data using UMAP","volume":"37","author":"Becht","year":"2018","journal-title":"Nat Biotechnol"},{"key":"2024071516104547500_bib22","unstructured":"Zeileis\n              A\n            \n          . ineq: measuring inequality, concentration, and poverty. Accessed 21 July 2014. https:\/\/CRAN.R-project.org\/package=ineq."},{"issue":"12","key":"2024071516104547500_bib23","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"issue":"1","key":"2024071516104547500_bib24","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s13059-015-0844-5","article-title":"MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data","volume":"16","author":"Finak","year":"2015","journal-title":"Genome Biol"},{"issue":"1","key":"2024071516104547500_bib25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nprot.2014.006","article-title":"Full-length RNA-seq from single cells using Smart-seq2","volume":"9","author":"Picelli","year":"2014","journal-title":"Nat Protoc"},{"issue":"7","key":"2024071516104547500_bib26","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/nbt.1883","article-title":"Full-length transcriptome assembly from RNA-seq data without a reference genome","volume":"29","author":"Grabherr","year":"2011","journal-title":"Nat Biotechnol"},{"issue":"5","key":"2024071516104547500_bib27","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nbt.3519","article-title":"Near-optimal probabilistic RNA-seq quantification","volume":"34","author":"Bray","year":"2016","journal-title":"Nat Biotechnol"},{"issue":"4","key":"2024071516104547500_bib28","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1038\/s41596-020-0292-x","article-title":"CellPhoneDB: inferring cell\u2013cell communication from combined expression of multi-subunit ligand\u2013receptor complexes","volume":"15","author":"Efremova","year":"2020","journal-title":"Nat Protoc"},{"issue":"60","key":"2024071516104547500_bib29","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.21105\/joss.03021","article-title":"seaborn: statistical data visualization","volume":"6","author":"Waskom","year":"2021","journal-title":"J\u00a0Open Source Softw"},{"issue":"43","key":"2024071516104547500_bib30","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci"},{"issue":"591","key":"2024071516104547500_bib31","doi-asserted-by":"crossref","first-page":"eabd8836","DOI":"10.1126\/scitranslmed.abd8836","article-title":"SynNotch CAR circuits enhance solid tumor recognition and promote persistent antitumor activity in mouse models","volume":"13","author":"Hyrenius-Wittsten","year":"2021","journal-title":"Sci Transl Med"},{"key":"2024071516104547500_bib32","unstructured":"Roman\n              G\n            \n          . Bcma (cd269) specific chimeric antigen receptors for cancer immunotherapy. Google Patents. Accessed 4 November 2019. https:\/\/patents.google.com\/patent\/US20170183418."},{"issue":"1","key":"2024071516104547500_bib33","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s13059-018-1603-1","article-title":"Cell Hashing with barcoded antibodies enables multiplexing and doublet detection for single cell genomics","volume":"19","author":"Stoeckius","year":"2018","journal-title":"Genome Biol"},{"issue":"5","key":"2024071516104547500_bib34","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41592-019-0392-0","article-title":"Multiplexed detection of proteins, transcriptomes, clonotypes and CRISPR perturbations in single cells","volume":"16","author":"Mimitou","year":"2019","journal-title":"Nat Methods"},{"issue":"1","key":"2024071516104547500_bib35","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nbt.4042","article-title":"Multiplexed droplet single-cell RNA-sequencing using natural genetic variation","volume":"36","author":"Kang","year":"2018","journal-title":"Nat Biotechnol"},{"issue":"2","key":"2024071516104547500_bib36","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","article-title":"Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage","volume":"20","author":"Aran","year":"2019","journal-title":"Nat Immunol"},{"issue":"3","key":"2024071516104547500_bib37","first-page":"278","article-title":"Toward a more normative assessment of maldistribution: the Gini Index","volume":"14","author":"Morrow","year":"1977","journal-title":"Inquiry"},{"issue":"11","key":"2024071516104547500_bib38","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1101\/gr.154815.113","article-title":"Network properties derived from deep sequencing of human B-cell receptor repertoires delineate B-cell populations","volume":"23","author":"Bashford-Rogers","year":"2013","journal-title":"Genome Res"},{"issue":"9","key":"2024071516104547500_bib39","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1038\/s41591-022-01959-0","article-title":"Distinct cellular dynamics associated with response to CAR-T therapy for refractory B cell lymphoma","volume":"28","author":"Haradhvala","year":"2022","journal-title":"Nat Med"},{"issue":"9","key":"2024071516104547500_bib40","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1038\/s41591-022-01960-7","article-title":"Post-infusion CAR TReg cells identify patients resistant to CD19-CAR therapy","volume":"28","author":"Good","year":"2022","journal-title":"Nat Med"},{"issue":"12","key":"2024071516104547500_bib41","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1038\/s41591-020-1061-7","article-title":"Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas","volume":"26","author":"Deng","year":"2020","journal-title":"Nat Med"},{"issue":"6","key":"2024071516104547500_bib42","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1158\/2643-3230.BCD-22-0018","article-title":"Changes in bone marrow tumor and immune cells correlate with durability of remissions following BCMA CAR T therapy in myeloma","volume":"3","author":"Dhodapkar","year":"2022","journal-title":"Blood Cancer Discov"},{"issue":"7","key":"2024071516104547500_bib43","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.cell.2020.05.017","article-title":"Intratumoral CD4+ T cells mediate anti-tumor cytotoxicity in human bladder cancer","volume":"181","author":"Oh","year":"2020","journal-title":"Cell"},{"issue":"7897","key":"2024071516104547500_bib44","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-021-04390-6","article-title":"Decade-long leukaemia remissions with persistence of CD4+ CAR T cells","volume":"602","author":"Melenhorst","year":"2022","journal-title":"Nature"},{"issue":"12","key":"2024071516104547500_bib45","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1158\/2159-8290.CD-15-1347","article-title":"TGF\u03b21-mediated SMAD3 enhances PD-1 expression on antigen-specific T cells in cancer","volume":"6","author":"Park","year":"2016","journal-title":"Cancer Discov"},{"key":"2024071516104547500_bib46","doi-asserted-by":"crossref","first-page":"832645","DOI":"10.3389\/fimmu.2022.832645","article-title":"Armored BCMA CAR T cells eliminate multiple myeloma and are resistant to the suppressive effects of TGF-\u03b2","volume":"13","author":"Alabanza","year":"2022","journal-title":"Front Immunol"},{"issue":"4","key":"2024071516104547500_bib47","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41591-022-01726-1","article-title":"PSMA-targeting TGF\u03b2-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial","volume":"28","author":"Narayan","year":"2022","journal-title":"Nat Med"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/13\/3562\/2234959\/blooda_adv-2023-012416-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/13\/3562\/2234959\/blooda_adv-2023-012416-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T16:11:07Z","timestamp":1721059867000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/13\/3562\/515581\/CD4-CAR-T-cell-exhaustion-associated-with-early"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,9]]},"references-count":47,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2024,7,9]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023012416","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,9]]}}}